Thank you.
I want to talk a bit about the testimony we heard in regard to mefloquine. Health Canada has updated concerns as of August in regard to the long-term impact of mefloquine. Does VAC intend to address the needs of veterans who were denied benefits because of a lack of understanding of the impact of the drug? Will VAC reach out to veterans who have previously been denied services in order to make sure that their needs are met?
Finally, what kind of support can or will VAC provide for mefloquine survivors, those who are still experiencing the symptoms of night sweats, insomnia, and suicidal thoughts?